Results 151 to 160 of about 115,857 (253)
ABSTRACT Objectives Digital morphology (DM) systems assisted by artificial intelligence are increasingly being introduced into hematology laboratories; however, data on their performance in routine clinical practice for bone marrow aspirates (BMA) remain limited.
Gina Zini +6 more
wiley +1 more source
OBJECTIVE: The JAK2 46/1 haplotype has recently been described as a major contributing factor to the development of myeloproliferative neoplasm, whether positive or negative forthe JAK2 V617F mutation.
Sarah Pagliarini-e-Silva +6 more
doaj
ABSTRACT Introduction RUNX1 is a commonly mutated transcriptional regulator of hematopoiesis in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Mutated RUNX1 (mRUNX1) may associate with cross‐lineage immunophenotypic aberrancy, presenting potential complications for blast lineage assignment at diagnosis. Methods Clinical and laboratory
Yi Han Xia, Eric McGinnis
wiley +1 more source
An agenda for future research projects in polycythemia vera and essential thrombocythemia
Tiziano Barbui +4 more
doaj +1 more source
Genomic Evolution of Myeloproliferative Neoplasms and Therapy-Associated Mutagenesis. [PDF]
Leongamornlert D +18 more
europepmc +1 more source
Cytogenetic Diversity of Variant Philadelphia Translocations in Chronic Myeloid Leukemia
ABSTRACT Introduction Chronic myeloid leukemia (CML) is a disease characterized by Philadelphia (Ph) translocations. These translocations can be classical or variant. The structural features and diagnostic implications of variant Philadelphia translocations remain incompletely defined, and they display considerable cytogenetic heterogeneity. Methods In
Ayse Gul Bayrak Tokac +10 more
wiley +1 more source
Are thrombosis, progression, and survival in ET predictable?
Ghaith Abu-Zeinah +7 more
doaj +1 more source
The Current Landscape of Pulmonary Hypertension in Myeloproliferative Neoplasms. [PDF]
Ferrante M, Ali HJ, Hobbs G, Leiva O.
europepmc +1 more source
The thrombopoietin receptor S264F mutant drives MPN with marrow fibrosis through a dual mechanism
HemaSphere, Volume 10, Issue 10, October 2026.
Charlotte Lees +9 more
wiley +1 more source

